Bone Therapeutics’ allogeneic cell therapy product, ALLOB, shows 90% fusion rate at 24 months in Phase IIa study in lumbar spinal fusion
October 14, 2020 01:00 ET | Bone Therapeutics SA
90% of patients show bone fusion as well as strong clinical improvements in function and pain at 24 months follow-up period with a good product safety profile Gosselies, Belgium, 14 October...
Bone Therapeutics: Le produit de thérapie cellulaire allogénique, ALLOB, montre un taux de fusion des vertèbres lombaires de 90% à 24 mois dans l’étude de phase IIa
October 14, 2020 01:00 ET | Bone Therapeutics SA
90% des patients présentent une fusion osseuse ainsi que de fortes améliorations cliniques de la capacité fonctionnelle et de la réduction de la douleur, à 24 mois de suivi, avec un bon profil de...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Adds Mesenchymal Stem Cell Program (MSC) That Has Been Cleared for a Phase 1 Trial by the FDA to the Pipeline of COVID-19 Focused Rescue Therapies
October 12, 2020 17:21 ET | Sorrento Therapeutics, Inc.
SAN DIEGO, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") announced today that it has entered into an exclusive license agreement with Personalized Stem...
Bone Therapeutics to present at 2020 Virtual Cell & Gene Meeting on the Mesa
October 12, 2020 01:00 ET | Bone Therapeutics SA
Gosselies, Belgium, 12 October 2020, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases,...
Bone Therapeutics participe à la conférence virtuelle Cell & Gene Meeting on the Mesa
October 12, 2020 01:00 ET | Bone Therapeutics SA
Gosselies, Belgique, le 12 octobre 2020, 7h00 CEST – BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée dans le développement de thérapies cellulaires...
Bone Therapeutics, Link Health and Pregene to develop and commercialize the ALLOB allogeneic bone cell therapy platform in China and Southeast Asia
October 05, 2020 01:00 ET | Bone Therapeutics SA
Regulated Information Bone Therapeutics grants exclusive license to Link Health and Pregene for the development and commercialization of ALLOB in Greater China and a number of other major Asian...
Bone Therapeutics, Link Health et Pregene s’associent pour le développement et la commercialisation de la plateforme de thérapie cellulaire allogénique en Chine et en Asie du Sud-Est
October 05, 2020 01:00 ET | Bone Therapeutics SA
Information Réglementée Signature d’un accord de licence exclusif avec Link Health et Pregene pour le développement et la commercialisation d’ALLOB en Grande Chine et dans plusieurs autres...
Studio City Logo_v3.jpg
Studio City International Holdings Limited Announces Unaudited Second Quarter 2020 Earnings
August 20, 2020 07:54 ET | Studio City International Holdings Limited
MACAU, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today...
Studio City Logo_v3.jpg
Studio City Announces Earnings Release Date
August 13, 2020 06:43 ET | Studio City International Holdings Limited
MACAU, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC), a world-class integrated resort located in Cotai, Macau, today announces that it will furnish its...
Studio City Logo_v3.jpg
Studio City Announces Update on Private Placements
August 03, 2020 06:24 ET | Studio City International Holdings Limited
MACAU, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today...